Smith Lillian - Insider Non-Derivative Transactions at Allogene Therapeutics, Inc. (ALLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 1, 2023, Smith Lillian's relationship to Allogene Therapeutics, Inc. (ALLO) is Officer (VP, Corporate Counsel), and currently has 140,390 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALLO insiders.
Data Source: SEC.
Smith Lillian - Insider Non-Derivative Transactions at ALLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 2, 2023 | Acquisition -- (Common Stock) | 56545 | 0 | 140390 |